olivLaw · European equity research
Danone BN.PA
France · Euronext Paris · ISIN FR0000120644 · Vertical: Listed companies from France
Danone is a global food group active in three categories: dairy and plant-based products (EDP), specialised nutrition and waters. In fiscal 2024 it grew +4.3 % like-for-like, and its recurring operating margin rose to 13.0 %, while for 2025 the group sets a like-for-like revenue growth target between +3 % and +5 %.
At the close of 04 Nov 2026, Danone (BN.PA) stock was 67.64 EUR (+2.45% on the day), with market capitalisation 43.5 bn EUR, P/E 21.6 on diluted EPS of 3.13 EUR over the last 12 months, beta 0.15, 52-week range 57.58–79.60 EUR.
Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 75.1
- overbought (≥ 70)
- Bollinger (20, 2)
- 57.06 – 67.20
- above the upper band · %B 1.04 · band width 16.3%
- SMA 50 / 200
- 61.67 / 66.55
- mixed trend
- MACD (12, 26, 9)
- 1.43 / 0.68
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | +17.1% | +0.4% | +16.7 pp | — |
| 3 months | −0.5% | −3.3% | +2.7 pp | — |
| 6 months | +4.2% | +4.0% | +0.2 pp | — |
| Year to date | −11.9% | +8.1% | −20.0 pp | — |
| 1 year | −12.3% | +10.7% | −23.0 pp | −7.0% |
| 3 years | +18.6% | +50.1% | −31.5 pp | −17.3% |
| 5 years | +17.9% | +43.6% | −25.7 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 33 percentile of its own 3-quarter history (min 20.8, median 33.3, max 43.1; quarters with earnings only).
Fiscal years
| Fiscal year | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 27.7 bn | 27.6 bn | 27.4 bn |
| Revenue YoY | unavailable | −0.2% | −0.9% |
| Net income | 959.0 m | 881.0 m | 2.0 bn |
| Net income YoY | unavailable | −8.1% | +129.4% |
| Diluted EPS | 1.48 | 1.36 | 3.13 |
| Diluted EPS YoY | unavailable | −8.1% | +130.1% |
| net % | 3.5% | 3.2% | 7.4% |
| Free cash flow | 2.1 bn | 2.6 bn | 2.9 bn |
Balance sheet & financial health
Fiscal year 2024 · 31 Dec 2024
- Cash
- 1.5 bn EUR
- Financial debt
- 4.6 bn EUR
- Net debt
- 3.2 bn EUR
- Equity
- 17.9 bn EUR
- Total assets
- 45.3 bn EUR
- Debt / equity
- 0.26x
- Current ratio
- 0.93x
- ROE
- 11.9%
- ROA
- 4.5%
- FCF margin
- 10.6%
Financial statements (source on every figure)
Revenue and net income (EUR)
Margins
Income statement · EUR
| Line | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|
| Revenue | 27.7 bn | 27.6 bn | 27.4 bn | esef· 24 Sept 2025verified |
| Cost of revenue | 14.9 bn | 14.5 bn | 13.8 bn | esef· 24 Sept 2025verified |
| Gross profit | 12.7 bn ≈ | 13.1 bn ≈ | 13.6 bn ≈ | esef· 24 Sept 2025derived |
| Research & development | 339.0 m | 398.0 m | 447.0 m | esef· 24 Sept 2025verified |
| Operating income | 2.1 bn | 2.0 bn | 3.4 bn | esef· 24 Sept 2025verified |
| Income tax | 778.0 m | 768.0 m | 929.0 m | esef· 24 Sept 2025verified |
| Net income | 959.0 m | 881.0 m | 2.0 bn | esef· 24 Sept 2025verified |
| Diluted EPS | 1.48 | 1.36 | 3.13 | esef· 24 Sept 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue.
Balance sheet · EUR
| Line | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|
| Cash | 1.1 bn | 2.4 bn | 1.5 bn | esef· 24 Sept 2025verified |
| Inventories | 2.6 bn | 2.3 bn | 2.3 bn | esef· 24 Sept 2025verified |
| Current assets | 12.2 bn | 12.9 bn | 12.8 bn | esef· 24 Sept 2025verified |
| Property, plant & equipment, net | 6.8 bn | 6.4 bn | — | esef· 18 Mar 2024verified |
| Goodwill | 17.9 bn | 17.3 bn | 18.1 bn | esef· 24 Sept 2025verified |
| Total assets | 45.3 bn | 44.5 bn | 45.3 bn | esef· 24 Sept 2025verified |
| Short-term debt | 3.6 bn | 5.5 bn | 4.6 bn | esef· 24 Sept 2025verified |
| Current liabilities | 12.1 bn | 14.0 bn | 13.7 bn | esef· 24 Sept 2025verified |
| Equity | 18.0 bn | 16.2 bn | 17.9 bn | esef· 24 Sept 2025verified |
| Shares outstanding at year end | 648.0 m | 647.8 m | 643.6 m | esef· 24 Sept 2025derived |
Cash flow · EUR
| Line | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|
| Operating cash flow | 3.0 bn | 3.4 bn | 3.8 bn | esef· 24 Sept 2025verified |
| Capex | 873.0 m | 847.0 m | 923.0 m | esef· 24 Sept 2025verified |
| Free cash flow | 2.1 bn ≈ | 2.6 bn ≈ | 2.9 bn ≈ | esef· 24 Sept 2025derived |
| Investing cash flow | -749.0 m | -834.0 m | -463.0 m | esef· 24 Sept 2025verified |
| Financing cash flow | -1.9 bn | -2.1 bn | -3.8 bn | esef· 24 Sept 2025verified |
| Share repurchases | 0 | 0 | 0 | esef· 24 Sept 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 52.1% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 43.5 bn EUR
Key indicators
Coverage and freshness
The data is older than the freshness threshold.
Score by group
52% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 34.24 – 93.69 EUR.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (EUR per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/E34.24 – 93.69 (Mid 53.04)20 companies used · median multiple 16.9x · quartiles 10.9x – 29.9x74SW.PA, ABEO.PA, AC.PA, ADP.PA, AF.PA, AI.PA, ALBON.PA, ALCIS.PA, ALCLA.PA, ALFER.PA, ALHEX.PA, ALO.PA, ALPWG.PA, ALSOG.PA, ANTIN.PA, ARAMI.PA, ATE.PA, AUB.PA, AURE.PA, BB.PA
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Assumptions (illustrative, editorial)
- Risk-free rate
- 3.0%
- Equity risk premium
- 5.5%
- Beta (default)
- 1.00
- Cost of equity
- 8.5%
- Terminal growth
- 2.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 52.1% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 14.1% | 71 (vs peers) | 20% |
| Net margin · Quality | 7.4% | 82 (vs peers) | 12% |
| FCF conversion · Quality | 143.9% | 100 (on a fixed band) | 12% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 0.9x | 11 (on a fixed band) | 8% |
| P/E (TTM) · Valuation | 21.6x | 43 (vs peers) | 20% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 6.7% | 83 (on a fixed band) | 16% |
| Shareholder yield (distributions) · Returns | 0.0% | 0 (on a fixed band) | 12% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial11/100 · 1/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality82/100 · 3/3 factors with a value
- Returns· partial0/100 · 1/2 factors with a value
- Valuation61/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
DANONE (BN.PA). Latest full fiscal year: 2024; data up to 2024-12-31.
Figures computed from the financial statements: revenue 27.4 bn EUR in 2024; YoY growth -0.9%; net margin 7.4%; ROE 11.9%.
The estimated value range is 34.24–93.69 EUR per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 53.04 EUR, the price of 67.64 EUR leaves a potential of -21.6% (value / price − 1) and a margin of safety of -27.5% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 52.1% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- ROIC: 14.1%
- Net margin: 7.4%
- FCF conversion: 143.9%
- FCF yield: 6.7%
What contradicts it
- Current ratio: 0.9x
- Shareholder yield (distributions): 0.0%
Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, EV/EBITDA, Payout ratio (FCF).
Versus the vertical median
Listed companies from France · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| AI.PAL'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | 107.9 bn | 32.8 | 12.9% | 12.2% | −2.0% | +25% / +30% |
| BN.PADanone | 43.5 bn | 21.6 | 11.9% | 7.4% | −0.9% | −12% / +15% |
| AC.PAAccor | 13.8 bn | 30.7 | 9.6% | 8.0% | +0.6% | +6% / +55% |
| ADP.PAAeroports De Paris | 11.6 bn | 34.0 | 7.8% | 5.6% | +12.1% | −7% / +4% |
| AKE.PAArkema | 7.0 bn | 113.4 | 0.9% | 0.7% | −5.0% | +10% / −38% |
| ALO.PAAlstom | 5.9 bn | 18.6 | 3.1% | 1.7% | +3.7% | −51% / −2% |
| AF.PAAir France - Klm | 3.8 bn | 12.1 | — | 1.0% | +4.8% | +7% / −3% |
| ATE.PAAlten | 3.1 bn | 29.7 | 4.8% | 2.6% | −1.1% | +34% / −28% |
| BB.PASociete Bic | 2.6 bn | 30.8 | 5.0% | 4.1% | −4.8% | +30% / +4% |
| ANTIN.PAAntin Infrastructure Partners | 1.4 bn | 13.1 | 21.9% | 36.6% | −8.1% | −23% / −34% |
| 74SW.PA74software | 806.8 m | 21.2 | 8.9% | 8.5% | +44.8% | −11% / +43% |
| AUB.PAAubay | 671.2 m | 17.9 | 13.6% | 6.3% | +11.3% | +4% / +46% |
| ASY.PAAssystem | 507.8 m | 70.0 | 2.5% | 1.1% | +7.4% | −19% / −18% |
| ATO.PAAtos Se | 503.9 m | — | -23,400.0% | -17.5% | −16.5% | −42% / −94% |
| ARAMI.PAAramis Group | 293.9 m | 14.8 | 10.0% | 0.8% | +6.3% | −34% / −17% |
| ARVEN.PAArverne Group | 246.9 m | — | -14.0% | -115.3% | +27.0% | +20% / −34% |
| BGO.PACompagnie Chargeurs Invest | 184.8 m | — | -8.6% | -5.7% | −2.9% | unavailable / unavailable |
| ALCIS.PACatering International & Services | 148.2 m | 29.0 | 9.3% | 1.9% | +5.8% | +42% / +111% |
| ALCGM.PACegedim | 145.3 m | — | -2.6% | -1.2% | +10.9% | −25% / −49% |
| ALHEX.PAHexaom | 143.3 m | 6.6 | 9.9% | 2.2% | +13.1% | −32% / +7% |
| ATEME.PAAteme | 133.9 m | 140.6 | 2.8% | 1.0% | +2.2% | +69% / +65% |
| ALBON.PACompagnie Lebon | 108.5 m | 16.0 | 4.2% | 8.8% | −17.9% | +3% / +5% |
| ALHYF.PALhyfe | 75.9 m | — | -33.4% | -570.5% | +287.2% | unavailable / unavailable |
| ABEO.PAAbeo | 62.3 m | 7.4 | 6.9% | 3.0% | +12.6% | −11% / −53% |
| ALFER.PASergeferrari Group | 60.6 m | 11.3 | 5.1% | 1.5% | +7.4% | −34% / −28% |
1- and 3-year price returns: for BN.PA from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (EUR)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 37.94 Total return -44% · Per year -44% | 67.26 Total return -1% · Per year -1% | 101.56 Total return 50% · Per year 50% |
| 3 years | 32.95 Total return -51% · Per year -21% | 66.08 Total return -2% · Per year -1% | 110.10 Total return 63% · Per year 18% |
| 5 years | 28.61 Total return -58% · Per year -16% | 64.92 Total return -4% · Per year -1% | 119.36 Total return 76% · Per year 12% |
- Exit P/E± 16.52
- Net margin± 11.56
- Annual revenue growth± 10.01
- Annual dilution± 0.97
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Danone is a global food group active in three categories: dairy and plant-based products (EDP), specialised nutrition and waters. In fiscal 2024 it grew +4.3 % like-for-like, and its recurring operating margin rose to 13.0 %, while for 2025 the group sets a like-for-like revenue growth target between +3 % and +5 % 1.
SWOT
Strengths
- Diversified portfolio across categories and geographies, with a strong position in specialised nutrition and waters.
- High productivity and the ability to generate solid free cash flow, which supports investment and dividends.
- Globally recognised brands and health-oriented innovation, with new launches in specialised nutrition.
Weaknesses
- Dependence on the EDP category, which has the lowest operating margin among the group's categories.
- Sensitivity to exchange rates, which reduce revenue reported in euros.
- Brand reinvestment and transformation costs that weigh on margin in some periods.
Opportunities
- Growing demand for high-protein and plant-based products, which could open new segments.
- Expansion in Asian and African markets, where dairy and nutrition categories showed positive momentum.
- Reduction of CO2 emissions through lower-carbon ingredients, which could support demand from environmentally conscious consumers.
Threats
- Intense competition from international groups and local brands in core categories.
- Currency fluctuations and instability in economies under hyperinflation.
- Regulatory pressure on sugar content and food labelling.
Risks
- Currency exposuremedium
Movements of currencies against the euro could reduce reported revenue, as happened in fiscal 2024 1.
- Transformation costsmedium
Exceptional costs of transformation projects, mainly in Europe and the United States, weighed on non-recurring results 1.
- Hyperinflation accountingmedium
Applying hyperinflation accounting rules can change reported results in affected countries 1.
- Cost of financinglow
Higher interest rates increased net financial cost, which could weigh on profit if rates stay high 1.
- Sugar and health regulationmedium
Regulatory pressure on sugar content could change product formulations and associated costs 1.
Investment thesis
What would need to be true (bull case)
- Growth like-for-like and a rising operating margin show solid execution, supported by productivity and a portfolio oriented to specialised nutrition.
- Rising free cash flow and the 2025 guidance could support investment and dividends if the 2024 trends hold.
- Innovation in high-protein and plant-based products could open new growth segments.
What would break the thesis
- The EDP category, the group's largest, has a lower operating margin and more modest growth, which could limit overall progress.
- Negative currency effects and deconsolidations reduced published revenue, and this effect could persist.
- Brand reinvestment and transformation costs could keep weighing on margin if competitive pressure increases.
What to watch
- Delivery of the like-for-like revenue growth guidance2025
- Development of the recurring operating margin in EDP2025
- Effect of exchange rates on published revenuenext 10-K
- Momentum of specialised nutrition sales in Europe and China2025
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Danone organises its activity across five geographic zones and three categories: EDP (dairy and plant-based products), Specialised Nutrition and Waters. In fiscal 2024 consolidated revenue was 27376 million euros, and Specialised Nutrition kept the highest operating margin at 20.6 % 1. The group reported free cash flow of 3003 million euros, reflecting higher recurring operating profit and an improved working capital requirement 1.
Segments
Specialised Nutrition
With 8936 million euros of revenue in fiscal 2024 and +4.6 % growth like-for-like, this category includes infant formula and medical nutrition. Its recurring operating margin stayed high at 20.6 % 1. High-protein plant-based products and launches for children with growth problems are highlighted as innovation drivers 1.
EDP (dairy and plant-based products)
The largest category, with 13463 million euros of revenue in fiscal 2024 and +3.8 % growth like-for-like. Its recurring operating margin was 8.5 %, stable versus the prior year 1.
Market context
Trends
- High-protein dairy and plant-based productstailwind
Launches such as Fortimel Plant-Based High Energy High Protein and Fortimel Omega Care are presented as responses to consumer demand for products good for health. If demand holds, the segment could support growth in Specialised Nutrition 1.
- Exchange rate effectsheadwind
The weakening of some currencies against the euro reduced published revenue, a negative impact that weighed on results reported in euros 1. If the trend continues, euro-reported growth could remain below like-for-like growth.
- Operational efficiency and brand reinvestmentmixed
The group achieved record productivity levels that supported operating margin, but part of the gain was reinvested in brands, with a negative margin effect 1. The balance between the two could shape margin development in the coming years.
Competitive position
Danone competes in dairy and plant-based foods, infant nutrition and bottled waters against international food groups and local brands. The official source does not name competitors explicitly, so the list below is limited to what can be supported from the document.
The group's differentiation rests on innovation in specialised nutrition and on strong brands in waters and coffee-related products, which help it maintain margin in the face of competitive pressure 1.
- Nestlé
Global competitor in dairy, infant nutrition and waters, relevant to Danone's core categories.
- Lactalis
International dairy group present in the same dairy and infant formula categories.
- Local dairy and mineral water brands
Regional producers competing with Danone in European, Asian and Latin American markets.
- Plant-based food producers
Companies specialised in plant-based alternatives that compete in the plant-based EDP segment.
News & filings
In the press
- Danone Sales Rise on Higher Prices, Medical Nutrition DemandBloomberg Markets · 28 Oct 2026 · EN
- Coca-Cola, Nestlé și Danone schimbă etichetele sticlelor. Ce au anunțat că vor modifica - Wall-Street.roSurge — Google News · 23 Oct 2026 · RO
- Coca-Cola, Nestlé și Danone schimbă mesajele de pe sticlele din plastic. Ce informații vor primi consumatorii - Capital.roCapital.ro · 22 Oct 2026 · RO
- Coca-Cola, Nestlé și Danone vor modifica mențiunile privind reciclarea sticlelor de plasticJuridice.ro · 22 Oct 2026 · RO
- Coca-Cola, Danone și Nestle anunță schimbări la etichetele privind reciclarea sticlelor de plasticProfit.ro · 22 Oct 2026 · RO
- Comisia salută angajamentele Coca-Cola, Nestlé și Danone de a modifica mențiunile privind reciclarea sticlelor de plastic - Reprezentanța Comisiei Europene în RomâniaSurge — Google News · 22 Oct 2026 · RO
- Coca-Cola, Nestlé și Danone, obligate să modifice informațiile despre reciclare de pe sticlele din plastic - telegraph.mdSurge — Google News · 22 Oct 2026 · RO
- Coca-Cola, Nestlé și Danone își modifică etichetele după 3 ani de negocieri cu Comisia Europeană / Vor scrie că dopul nu e reciclat, ci doar recipientulG4Media · 22 Oct 2026 · RO
- Huel CEO on Danone Deal and Expansion to US RetailBloomberg Markets · 14 Oct 2026 · EN
- Putin puts U.S.-based packaging company AptarGroup’s Russian factory under temporary management by Danone’s former Russian armMeduza English (independent RU/exile) · 21 Sept 2026 · EN
- Adrian Pascu, primul român care a ocupat o funcţie de conducere în businessul Danone în regiune, pleacă după mai bine de 20 de ani în companie. În locul lui Adrian Pascu în funcţia de managing director pentru Europa Centrală a fost numit Konrad Kowalik.Ziarul Financiar · 03 Sept 2026 · RO
- Danone are un nou Managing Director pentru Europa Centrală. Va coordona operațiunile din România și alte patru țăriEconomedia · 02 Sept 2026 · RO
- FOTO Danone schimbă conducerea și în RomâniaProfit.ro · 02 Sept 2026 · RO
- Adrian Pascu pleacă după 20 de ani din Danone. În funcţia de managing director în regiune a fost numit Konrad KowalikZiarul Financiar · 02 Sept 2026 · RO
- Danone Sales Climb on High Protein, Medical Nutrition DemandBloomberg Markets · 29 Jul 2026 · EN
- George Năstase, director financiar pentru regiunea Europa Centrală şi de Est (FMCG) în cadrul grupului francez Danone, se desparte de companie după patru aniZiarul Financiar · 24 Jul 2026 · RO
- Războiul iaurturilor: Un conflict între Danone şi Chobani evidenţiază lupta pentru piaţa produselor bogate în proteineMoney.ro · 22 Jun 2026 · RO
- Yogurt wars: Danone-Chobani clash underscores wider protein battleThe Japan Times · 22 Jun 2026 · RO
- Danone extinde gama Alpro cu Alpro Matcha Coconut, o băutură pe bază de plante gata de consumHotNews.ro · 16 Jun 2026 · RO
- Danone România pariază pe exporturi: investiţii de 10 milioane de euro pentru o linie unde va produce iaurturi pentru Bulgaria, Spania, Franţa şi Italia. Produsele fabricii Danone din cartierul bucureştean Colentina ajung pe 18 pieţeZiarul Financiar · 03 Jun 2026 · RO
Annual reports (ESEF)
- Annual report 202424 Sept 2025
- Annual report 202318 Mar 2024
Sources
- [1] Annual report, fiscal year ended 2024-12-31 (ESEF) · SEC / Danone · 31 Dec 2024
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.